Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21337 | 364 | 39.1 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MEGSIN | Author keyword | 8 | 60% | 2% | 9 |
| 2 | SERPINB2 | Author keyword | 7 | 64% | 2% | 7 |
| 3 | PAI 2 | Author keyword | 6 | 26% | 5% | 19 |
| 4 | PLASMINOGEN ACTIVATOR INHIBITOR 2 | Author keyword | 5 | 33% | 3% | 12 |
| 5 | OV SERPIN | Author keyword | 4 | 67% | 1% | 4 |
| 6 | PI 6 | Author keyword | 4 | 67% | 1% | 4 |
| 7 | PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2 | Author keyword | 4 | 33% | 2% | 9 |
| 8 | OVALBUMIN FAMILY | Author keyword | 3 | 100% | 1% | 3 |
| 9 | INTRACELLULAR SERPIN | Author keyword | 2 | 67% | 1% | 2 |
| 10 | SPI3 | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MEGSIN | 8 | 60% | 2% | 9 | Search MEGSIN | Search MEGSIN |
| 2 | SERPINB2 | 7 | 64% | 2% | 7 | Search SERPINB2 | Search SERPINB2 |
| 3 | PAI 2 | 6 | 26% | 5% | 19 | Search PAI+2 | Search PAI+2 |
| 4 | PLASMINOGEN ACTIVATOR INHIBITOR 2 | 5 | 33% | 3% | 12 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+2 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+2 |
| 5 | OV SERPIN | 4 | 67% | 1% | 4 | Search OV+SERPIN | Search OV+SERPIN |
| 6 | PI 6 | 4 | 67% | 1% | 4 | Search PI+6 | Search PI+6 |
| 7 | PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2 | 4 | 33% | 2% | 9 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+2 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+2 |
| 8 | OVALBUMIN FAMILY | 3 | 100% | 1% | 3 | Search OVALBUMIN+FAMILY | Search OVALBUMIN+FAMILY |
| 9 | INTRACELLULAR SERPIN | 2 | 67% | 1% | 2 | Search INTRACELLULAR+SERPIN | Search INTRACELLULAR+SERPIN |
| 10 | SPI3 | 2 | 67% | 1% | 2 | Search SPI3 | Search SPI3 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MESANGIUM PREDOMINANT GENE | 12 | 63% | 3% | 12 |
| 2 | OVALBUMIN FAMILY | 11 | 56% | 4% | 14 |
| 3 | PCR RFLP DETECTION | 11 | 100% | 2% | 6 |
| 4 | PAI 2 | 7 | 44% | 3% | 12 |
| 5 | MONOCYTE NEUTROPHIL ELASTASE INHIBITOR | 6 | 71% | 1% | 5 |
| 6 | PAI 2 MESSENGER RNA | 6 | 100% | 1% | 4 |
| 7 | CHICKEN OVALBUMIN | 5 | 41% | 2% | 9 |
| 8 | PLASMINOGEN ACTIVATOR INHIBITOR 2 | 4 | 25% | 4% | 15 |
| 9 | PLACENTAL TYPE PAI 2 | 4 | 75% | 1% | 3 |
| 10 | INHIBITOR TYPE 2 | 3 | 31% | 2% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis | 2004 | 96 | 159 | 30% |
| PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2: STILL AN ENIGMATIC SERPIN BUT A MODEL FOR GENE REGULATION | 2011 | 9 | 130 | 43% |
| The undecided serpin - The ins and outs of plasminogen activator inhibitor type 2 | 2005 | 65 | 87 | 54% |
| BIOLOGICAL AND CLINICAL ASPECTS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 | 1995 | 211 | 264 | 31% |
| The plasminogen activating system in periodontal health and disease | 2002 | 26 | 37 | 46% |
| Association of Megsin 2093C/T, 2180C/T and C25663G gene polymorphism with the risk of IgA nephropathy | 2014 | 1 | 17 | 35% |
| Intracellular serpins in haemopoietic and peripheral blood cells | 2001 | 5 | 64 | 44% |
| Progress in the research of plasminogen activator inhibitor type-2 | 2000 | 0 | 29 | 62% |
| The cellular and molecular biology of plasminogen activator inhibitor type-2 | 1995 | 24 | 104 | 52% |
| The intracellular serpin family | 1996 | 14 | 44 | 30% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VASC BIOL VB1 | 2 | 26% | 1.6% | 6 |
| 2 | CLIVE WARD | 2 | 36% | 1.1% | 4 |
| 3 | MED PATHOL BLOOD SYST FDN | 1 | 100% | 0.5% | 2 |
| 4 | QUEENSLAND CANC FUND EXPT ONCOL PROGRAM | 1 | 40% | 0.5% | 2 |
| 5 | NEPHROL HYPERTENS METAB | 1 | 25% | 0.8% | 3 |
| 6 | STATISTICAL CONSULTING | 1 | 50% | 0.3% | 1 |
| 7 | VASC INFLAMMATORY MUSCULOSKELETAL | 1 | 50% | 0.3% | 1 |
| 8 | GEN PATHOL GIOVANNI XXIII | 0 | 33% | 0.3% | 1 |
| 9 | PLA STOMATOL | 0 | 33% | 0.3% | 1 |
| 10 | RHEUMATOL MUSCLE SKELETAL | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000216656 | UROKINASE RECEPTOR//UPAR//UPA |
| 2 | 0.0000210893 | UNITAT ANAT HUMANA EMBRIOL//UNITAT MED MATERNO FETAL//THROMBIN ANTITHROMBIN COMPLEXES |
| 3 | 0.0000198150 | SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3 |
| 4 | 0.0000160123 | MASPIN//SERPINB5//SERPIN B5 |
| 5 | 0.0000139819 | SPECIALTY CARE SERV//PULM CRIT CARE MEDMED//ANTIPLASMINS |
| 6 | 0.0000127685 | PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS |
| 7 | 0.0000099333 | NEUROSERPIN//PROTEASE NEXIN 1//PN 1 |
| 8 | 0.0000095793 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ANTITRYPSIN |
| 9 | 0.0000058248 | KANEMATSU//ISOLATED GLOMERULI//NEPHROL A |
| 10 | 0.0000054444 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR |